Avandia, a Case of Deja Vu all over again
Similar Posts
FDA Proposals Fail to Ensure Independent Drug Safety Assessment
In essence FDA proposals merely change the seating arrangement on the deck of the sinking Titanic. Eli Lilly announced that it intends to seek FDA approval for a long-lasting injectable form of Zyprexa (taken once a month).
NYS Hearing –AIDS Drug /Vaccine Experiments on Foster Children
Testimony by Vera Hassner Sharav, President ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Hearing of the NYS Assembly Committee on Health and Committee on Children and Families September 8, 2005 New York City I speak on behalf of the ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP), the organization that filed the…
In Medicine, the Power of No vs. Psychiatry’s Mass Overtreatment
Unlike patients in other fields of medicine, those who are designated mentally ill–or even declared to be "at risk" for mental illness in the future–are at once stigmatized and suffer losss of their autonomy.
Rebecca Riley’s Murderous Care Remembered
"Her mother’s murder trial has been over for a couple of weeks now, but I’m still haunted by little Rebecca Riley."
Petition to FDA: Withdraw Aricept 23mg Immediately
Public Citzen petitioned FDA Commissioner to immediately removal from market Pfizer’s Alzheimer’s drug, Aricept 23 mg dose, because of serious safety hazards and failure to demonstrate efficacy. The petition also urges FDA to add a label warning on Aricept and generic donepezil (5 mg and 10 mg) stating: "Use of 20 mg per day is counter indicated."
Columbia Brain Imaging Violations Condemned by Peers
"any slipshod work involving volunteers in clinical trials sends a shudder through the field," said Dr. Gary Small, a professor of psychiatry and biobehavioral sciences at UCLA